ForeSENTIA somatic cancer NIPD Genetics Logo (WIPO, 12/18/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ForeSENTIA somatic cancer NIPD Genetics was filed as Figurative mark on 12/18/2019 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Series of letters presenting different forms of writing #Series of letters in different dimensions #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1526163 |
| Register number | 018083688 |
| Countries | 
|
| Base trademark |
No. 018083688,
November 9, 2019
|
| Application date | December 18, 2019 |
| Expiration date | December 18, 2029 |
Trademark owner
31, Neas Engomis, Engomi
2409 Nicosia
CY
2409 Nicosia
CY
Trademark representatives
2-4, Arch. Makaros III Avenue,
Capital Center, 7th floor
CY
goods and services
01
Chemical analysis kits and reagents for genetic testing for
medical and scientific research purposes in the field of
cancer detection; chemical analysis kits and reagents for
cancer testing for medical and scientific research purposes;
nucleic acid based kits and reagents for testing cancer
diseases for medical and scientific research purposes
42
Medical laboratory services for testing of cancer and cancer
prevention; design and development of medical diagnostic
tests and products; medical and scientific research in the
field of genetic testing; providing medical and scientific
research information in the field of genetic testing;
genetic testing for scientific research and analysis
purposes in the field of cancer detection; genetic
engineering services; scientific, laboratory, clinical,
medical, and technological research and analysis services in
the fields of nucleic acid analysis, cancer testing, and
genetics; scientific research for medical purposes in the
area of cancerous diseases
44
Medical analysis services for the diagnosis and prognosis of
cancer; medical genetic testing services for diagnosis,
prevention and treatment of cancer; medical testing of blood
for diagnosis of cancer; genetic testing and genetic
counseling in the field of cancer detection; medical and
health services relating to DNA and genetics testing; RNA or
DNA analysis for cancer diagnosis and prognosis
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 19, 2021 | 2021/16 Gaz | UA | Rejection |
| February 2, 2021 | 2021/5 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 23, 2020 | 2020/53 Gaz | TR | Rejection |
| December 14, 2020 | 2020/51 Gaz | IN | Rejection |
| December 1, 2020 | 2020/49 Gaz | RS | Rejection |
| November 30, 2020 | 2020/50 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 1, 2020 | 2020/42 Gaz | IL | Rejection |
| September 28, 2020 | 2020/41 Gaz | RU | Rejection |
| May 18, 2020 | 2020/21 Gaz | US | Rejection |
| December 18, 2019 | 2020/15 Gaz | EM | Registration |
ID: 141526163